2 beaten-up ASX 200 shares I'd buy right now

I think these stocks look really good value.

| More on:
A older man and younger man rest, exhausted but happy after a good boxing session.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

I'm seeing many fine opportunities in S&P/ASX 200 Index (ASX: XJO) shares that have fallen in price and now look really good value.

Companies that have experienced significant share price declines in a relatively short period of time could be 'buy the dip' ideas.

Ideally, these should be companies delivering good underlying operational growth. This should allow them to deliver good returns for shareholders over the long term, whether they return to their former price/earnings (P/E) ratios or not.

With that in mind, these are two ASX 200 shares that look really appealing to me.  

Webjet Ltd (ASX: WEB)

Webjet is an ASX travel share. It's one of the largest (online) travel agents in Australia and also one of the largest business-to-business (B2B) travel operations in the world with its WebBeds segment.

The Webjet share price has fallen by 20% since 31 July 2023, as we can see on the chart below.

The company is still seeing strong growth from the surge in post-COVID travel, which the market may be underestimating considering international travel is still recovering to its former capacity.

Webjet has done considerable work, particularly within WebBeds, to utilise more technology and automation to increase efficiencies and profit margins.

Once the travel industry is back to strong volumes, I think Webjet will be able to demonstrate good profitability.

According to projections on Commsec, the ASX 200 travel share is valued at 21 times FY24's estimated earnings and under 17 times FY25's estimated earnings.

IGO Ltd (ASX: IGO)

This company is heavily focused on green commodities that can help with decarbonisation, namely nickel, copper, lithium, and cobalt.

I like looking at ASX mining shares that have gone through significant declines due to the cyclical nature of commodity prices. Bear in mind though, there's no knowing how long those cycles may be.

Since mid-July 2023, the IGO share price has declined by 40%, as we can see on the chart below.

I particularly like the collection of commodities that IGO is exposed to, given electrical vehicle demand is expected to keep ramping up in the years ahead.

There is less demand for lithium right now, which is why the lithium price has dropped off over the last few months. However, I think the projected shortfall in lithium in future years could reignite this sector in 2024.

If Chinese demand picks up again, I suspect the IGO share price could bounce quite nicely.

According to the projections on Commsec, the ASX 200 share is valued at eight times FY24's estimated earnings with a possible grossed-up dividend yield of around 5%.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

bull market model with a bull looking at a rising chart
Opinions

By December 2026, $1,000 invested in EOS shares could be worth…

With its share price taking off and contracts piling up, EOS is shaping up as one of the most compelling…

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

People with their hands underneath each other's hands holding a plant.
Growth Shares

2 ASX growth shares I'd buy today for growth and income

Both of these businesses are delivering excellent progress.

Read more »

Smiling woman with her head and arm on a desk holding $100 notes out, symbolising dividends.
Dividend Investing

1 ASX dividend stock down 17% I'd buy right now

I’d happily do some pre-Christmas portfolio shopping with this ASX dividend stock.

Read more »

Green arrow with green stock prices symbolising a rising share price.
Opinions

2 ASX shares to buy and hold for the next decade

I’m backing these ASX shares as long-term buys.

Read more »

a hand reaches out with australian banknotes of various denominations fanned out.
Opinions

2 incredible ASX shares I'd buy with $2,000 right now

These investments have global growth potential…

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Opinions

I'd buy this ASX dividend stock in any market

I’m planning to buy plenty more of this ASX stock in the coming months…

Read more »